František Kovář

8.9k total citations
27 papers, 324 citations indexed

About

František Kovář is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, František Kovář has authored 27 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 8 papers in Internal Medicine. Recurrent topics in František Kovář's work include Antiplatelet Therapy and Cardiovascular Diseases (13 papers), Atrial Fibrillation Management and Outcomes (12 papers) and Acute Myocardial Infarction Research (9 papers). František Kovář is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (13 papers), Atrial Fibrillation Management and Outcomes (12 papers) and Acute Myocardial Infarction Research (9 papers). František Kovář collaborates with scholars based in Slovakia, United Kingdom and United States. František Kovář's co-authors include Marián Mokáň, Ján Staško, Peter Kubisz, Matej Samoš, Gregory Y.H. Lip, Ronny Renfurm, Petr Kala, J. Wouter Jukema, Philippe Gabríel Steg and Christopher B. Granger and has published in prestigious journals such as European Heart Journal, Medicine and BioMed Research International.

In The Last Decade

František Kovář

26 papers receiving 312 citations

Peers

František Kovář
František Kovář
Citations per year, relative to František Kovář František Kovář (= 1×) peers Lucia Stančiaková

Countries citing papers authored by František Kovář

Since Specialization
Citations

This map shows the geographic impact of František Kovář's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by František Kovář with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites František Kovář more than expected).

Fields of papers citing papers by František Kovář

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by František Kovář. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by František Kovář. The network helps show where František Kovář may publish in the future.

Co-authorship network of co-authors of František Kovář

This figure shows the co-authorship network connecting the top 25 collaborators of František Kovář. A scholar is included among the top collaborators of František Kovář based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with František Kovář. František Kovář is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sokol, Juraj, et al.. (2019). Direct oral anticoagulants in oncology in clinical praxis. Vnitřní lékařství. 65(1). 45–50. 1 indexed citations
2.
Samoš, Matej, Tomáš Bolek, Lucia Stančiaková, et al.. (2018). Anti-Xa activity in oral factor Xa inhibitor-treated patients with atrial fibrillation and a higher risk of bleeding. Blood Coagulation & Fibrinolysis. 29(4). 369–373. 10 indexed citations
3.
Samoš, Matej, Tomáš Bolek, Ingrid Škorňová, et al.. (2018). Role of Thromboelastography and Rotational Thromboelastometry in the Management of Cardiovascular Diseases. Clinical and Applied Thrombosis/Hemostasis. 24(8). 1199–1207. 30 indexed citations
4.
Samoš, Matej, Tomáš Bolek, Lucia Stančiaková, et al.. (2017). Does type 2 diabetes affect the on-treatment levels of direct oral anticoagulants in patients with atrial fibrillation?. Diabetes Research and Clinical Practice. 135. 172–177. 8 indexed citations
5.
Studenčan, Martin, et al.. (2017). Prevalence of Conventional Cardiovascular Risk Factors in Patients with Acute Coronary Syndromes in Slovakia. Central European Journal of Public Health. 25(1). 77–84. 11 indexed citations
6.
Samoš, Matej, Lucia Stančiaková, František Kovář, et al.. (2017). Monitoring the hemostasis with rotation thromboelastometry in patients with acute STEMI on dual antiplatelet therapy. Medicine. 96(6). e6045–e6045. 6 indexed citations
7.
Sokol, Juraj, et al.. (2017). First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans. Clinical and Applied Thrombosis/Hemostasis. 24(6). 914–919. 14 indexed citations
8.
Samoš, Matej, František Kovář, Péter Galajda, et al.. (2016). The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study. Journal of Diabetes Research. 2016. 1–6. 1 indexed citations
9.
Kovář, František, et al.. (2016). [The role of epicardial fat and obesity parameters in the prediction of coronary heart disease].. PubMed. 62(4). 256–62. 1 indexed citations
10.
Samoš, Matej, Tomáš Bolek, Jela Ivanková, et al.. (2016). Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current Experiences. Journal of Cardiovascular Pharmacology. 68(5). 391–394. 11 indexed citations
11.
Sokol, Juraj, et al.. (2016). Acute arterial occlusions of the extremities as only one manifestation of cardiac myxoma. Cor et Vasa. 59(5). e481–e484. 1 indexed citations
12.
Samoš, Matej, František Kovář, Lucia Stančiaková, et al.. (2015). Ticagrelor. Blood Coagulation & Fibrinolysis. 27(2). 117–120. 9 indexed citations
13.
Studenčan, Martin, František Kovář, V. Hricak, et al.. (2014). Two-year survival of STEMI patients in Slovakia. An analysis of the SLOVak registry of Acute Coronary Syndromes (SLOVAKS). Cor et Vasa. 56(4). e297–e303. 1 indexed citations
14.
Samoš, Matej, František Kovář, Péter Galajda, et al.. (2014). Prasugrel loading dose in diabetic patients with acute STEMI - Always sufficiently effective? Observation in two cases and review of current knowledge. Cor et Vasa. 56(5). e388–e395. 1 indexed citations
15.
Samoš, Matej, František Kovář, Péter Galajda, et al.. (2014). Clopidogrel resistance in diabetic patient with acute myocardial infarction due to stent thrombosis. The American Journal of Emergency Medicine. 32(5). 461–465. 9 indexed citations
16.
Samoš, Matej, Ingrid Škorňová, Ján Staško, et al.. (2014). Monitoring the Efficacy of ADP Inhibitor Treatment in Patients With Acute STEMI Post-PCI by VASP-P Flow Cytometry Assay. Clinical and Applied Thrombosis/Hemostasis. 21(4). 334–338. 10 indexed citations
17.
Samoš, Matej, Lucia Stančiaková, Jela Ivanková, et al.. (2014). Monitoring of dabigatran therapy using Hemoclot® Thrombin Inhibitor assay in patients with atrial fibrillation. Journal of Thrombosis and Thrombolysis. 39(1). 95–100. 27 indexed citations
18.
Samoš, Matej, et al.. (2013). [Syncope as first and only sign of left atrial myxoma].. PubMed. 59(2). 132–5.
19.
Studenčan, Martin, V. Hricak, František Kovář, et al.. (2011). Implementation of ESC-STEMI guidelines into clinical practice: an analysis of the Slovak Registry of Acute Coronary Syndromes (SLOVAKS). Journal of Cardiovascular Medicine. 12(5). 353–355. 3 indexed citations
20.
Steg, Philippe Gabríel, Shamir R. Mehta, J. Wouter Jukema, et al.. (2011). RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome. European Heart Journal. 32(20). 2541–2554. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026